Abstract
Despite improvements during the last decades, heart transplantation remains associated with several medical complications, which limit clinical outcomes: acute rejection with hemodynamic compromise, cytomegalovirus (CMV) infections, allograft vasculopathy, chronic renal failure, and neoplasias. Everolimus, a proliferation signal inhibitor, represents a new option for adjunctive immunosuppressive therapy. Everolimus displays better efficacy in de novo heart transplant patients than azathioprine for prophylaxis of biopsy-proven acute rejection episodes of at least ISHLT grade 3A (P < .001), of allograft vasculopathy (P < .01), and of CMV infections (P < .01). These findings suggest that everolimus potentially play an important role as part of immunosuppressive therapy in heart transplant recipients. Heart transplant investigators from Latin America produced recommendations for everolimus use in daily practice based on available data and their own experience.
References
Sep 12, 1998·Transplantation·J KobashigawaH Valantine
Jan 11, 2000·Transplantation·M CantarovichJ S Barkun
Sep 27, 2000·Transplant Immunology·Z NikolovaR P Hof
Nov 22, 2000·Transplantation·A ReisR Sundmacher
Feb 8, 2002·Journal of Clinical Pharmacology·John M KovarikChristiane Rordorf
Feb 12, 2002·Pharmacotherapy·John M KovarikHans H Neumayer
Aug 29, 2003·The New England Journal of Medicine·Howard J EisenUNKNOWN RAD B253 Study Group
Oct 28, 2003·Transplantation·Yuji MatsumotoRobert P Hof
Apr 20, 2004·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Howard Eisen, Heather Ross
Aug 3, 2004·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·David O TaylorMarshall I Hertz
Dec 4, 2004·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Randall C StarlingHeinz Schmidli
Mar 19, 2005·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Hannah Valantine, Andreas Zuckermann
Mar 19, 2005·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Hans Lehmkuhl, Roland Hetzer
Mar 19, 2005·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Andreas Zuckermann
May 4, 2005·Transplantation Proceedings·B K KrämerUNKNOWN RADA2307 Study Group
May 18, 2005·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Howard J EisenUNKNOWN Mycophenolate Mofetil Cardiac Study Investigators
Jul 6, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Fernando BacalJosé Antonio Franchini Ramires
Citations
Jul 10, 2008·Expert Opinion on Drug Metabolism & Toxicology·Ana I Sánchez-Fructuoso
Jul 14, 2010·Transplantation Reviews·Nicolás ManitoJavier Segovia
Mar 21, 2009·Transplantation Reviews·Juan F DelgadoJosé M de la Torre
Sep 25, 2007·Transplantation Proceedings·J MoroA Salvador
Aug 19, 2007·Transplantation Proceedings·R FiocchiA Gamba
Mar 23, 2010·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Einar GudeArne K Andreassen